Major Topics:
1. Molecular mechanisms of aging-associated decline in stem cell function and their relevance to cancer.
2. Aging-associated DNA damage response pathways and genomic instability in cancer.
3. Epigenetic mechanism in aging and cancer.
4. Contributions of the microenvironment in aging-associated tumor formation.
5. Human premature aging disorders as model systems of aging-associated cancer formation.
6. Cancer intervention based on aging mechanisms.
Keynote Speaker:
Zhu Chen, Shanghai Institute of Hematology, CHINA
Abstract title: Aging and Cancer: Prevention and Treatment of Cancer in Aged Population
Speakers:
Jian-Jun Chen, University of Cincinnati, USA
Abstract title: TET Protein-Mediated DNA Epigenetics in Acute Myeloid Leukemia: Function, Mechanism and Therapeutics
Hugues de Thé, Collège de France, FRANCE
Abstract title: PML is a ROS sensor activating p53 upon oxidative stress
Ronald DePinho, The University of Texas MD Anderson Cancer Center, USA
Abstract title: Telomeres in Cancer, Aging, and Degenerative Disease
James DeGregori, University of Colorado, USA
Abstract title: Context-dependent oncogenic adaptation in the genesis of lung cancer in old age
Cynthia Dunbar, National Heart, Lung, & Blood Institute, NIH, USA
Eric Gilson, University of Nice, FRANCE
Abstract title: The telomeric protein TRF2 induces cancer immunosuppression via modification of the glycocalyx
Samir Hanash, The University of Texas MD Anderson Cancer Center, USA
Abstract title: Biomarker based personalized risk assessment and early detection of common cancers associated with aging
Leroy Hood, Institute for Systems Biology, USA
Abstract title: Systems medicine, big data and scientific wellness are transforming healthcare
Anne Janin, Université Paris Diderot, FRANCE
Abstract title: Cancer stem-cells and tumor heterogeneity
Zhenyu Ju, Jinan University, CHINA
Abstract title: Mitochondrial fitness regulates telomere dysfunction-driven cardiac aging and lifespan
Saadi Khochbin, Alpes University Institute for Advanced Biosciences, FRANCE
Abstract title: Cell Identity Loss in Cancer: a Source of New Biomarkers and Therapeutic Targets
Jonathan Licht, University of Florida Health Cancer Center, USA
Abstract title: NSD2 and Blood Malignancies of the Young and Old
Guanghui Liu, Institute of Biophysics, CAS, CHINA
Abstract title: Using stem cell and gene editing techniques to study and treat aging-associated disorders
Pier-Paolo Pandolfi, Harvard Medical School, USA
Abstract title: The Non-Coding RNA Revolution in Cancer Pathogenesis and Therapy
Robert Roeder, The Rockefeller University, USA
Abstract title: Mechanistic studies of Transcriptional Regulation in Leukemia and Lymphoma
Eric So, King's College London, UK
Abstract title: Origins of human MLL leukemia and their impacts on treatment responses
Zhou Songyang, Sun Yat-sen University, CHINA
Abstract title: Regulation of telomerase activity in human cells
Samuel Waxman, The Mount Sinai Medical Center, USA
Abstract title: Novel adjuvant therapy for triple negative breast cancer by targeting the chromatin modulator Sin3 interaction with PF1/MRG15/KDM5B complex
Yue Xiong, University of North Carolina at Chapel Hill, USA
Abstract title: Transcriptional regulation of p16INK4A
Hua Yu, City of Hope, USA
Abstract title: Novel antibody-based therapies for cancers including aging-related cancers
Arthur Zelent, University of Miami Health System, USA
We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (talk/poster) of abstracts will be posted on this web site as soon as decisions have been made by the organizers.
Fellowships:
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs attending the conference will be selected for fellowship (USD $100-$500) awards. For more details, please visit http://www.csh-asia.org/stipends.html
We look forward to seeing you at Suzhou in November, 2017.